Nazária Distribuidora Farmacêutica
| Primary URL | Location | Industry | Undetermined |
Country
Brazil
|
Pharmaceuticals
|
|---|
Profile
Nazária Distribuidora Farmacêutica is a pharmaceutical distributor headquartered in Brazil, engaged in the procurement, storage, and delivery of medicinal products to various points of care within the country’s health system. The company’s core activity involves moving drugs from manufacturers to pharmacies, hospitals, and other healthcare providers, thereby supporting the continuity of patient treatment. As a distributor, it operates under the regulatory framework established by Brazilian health authorities, which governs the handling, traceability, and safety of pharmaceutical goods. Its role in the supply chain positions it as an intermediary that helps ensure that medicines reach end users in a timely and compliant manner.
On May 12 2025, Nazária Distribuidora Farmacêutica reported a cyber attack that caused operational instabilities across its information technology systems. The incident prompted the organization’s technical team to prioritize containment and remediation efforts while reinforcing security measures to protect data and restore normal service. The company stated that it is working to resume operations as quickly as possible, focusing on stabilizing affected platforms and preventing further disruption. No details were disclosed regarding the nature or origin of the attack, nor whether any internal data had been compromised.
The same overview notes that Drogarias Globo, which is explicitly identified as part of Grupo Jorge Batista, disclosed a similar incident affecting its operations around the same time. Neither Nazária Distribuidora Farmacêutica nor Drogarias Globo provided information about potential data loss or whether the two events share a common source. Additionally, Grupo Jorge Batista has not issued a public statement concerning the cyber incidents involving its affiliated entities. This lack of detail leaves the broader implications and possible connections between the attacks unspecified.
No explicit information about the organization’s size, market reach, ownership structure, or parent‑subsidiary relationships is provided in the available sources. Consequently, any description of scale, financial metrics, or corporate affiliation beyond what is stated would constitute speculation and is omitted. The profile therefore remains confined to the confirmed facts concerning the company’s core function, the reported cyber incident, and the limited contextual details given in the incident overview.